What is the projected market valuation of the Neurovascular Devices Market by 2035?

The Neurovascular Devices Market is projected to reach a valuation of 10.03 USD Billion by 2035. Read More

What was the market valuation of the Neurovascular Devices Market in 2024?

In 2024, the Neurovascular Devices Market was valued at 5.24 USD Billion. Read More

What is the expected CAGR for the Neurovascular Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the Neurovascular Devices Market during the forecast period 2025 - 2035 is 6.08%. Read More

Which companies are considered key players in the Neurovascular Devices Market?

Key players in the Neurovascular Devices Market include Medtronic, Stryker, Boston Scientific, Terumo, Johnson & Johnson, Penumbra, MicroVention, Abbott, and Asahi Intecc. Read More

How much is the Interventional Neurology Devices segment projected to grow by 2035?

The Interventional Neurology Devices segment is projected to grow from 1.05 USD Billion in 2024 to 2.0 USD Billion by 2035. Read More

What is the projected growth for Neurovascular Stents from 2024 to 2035?

Neurovascular Stents are expected to grow from 1.2 USD Billion in 2024 to 2.3 USD Billion by 2035. Read More

Which application segment is expected to have the highest valuation by 2035?

The Ischemic Stroke application segment is expected to have the highest valuation, growing from 1.2 USD Billion in 2024 to 2.3 USD Billion by 2035. Read More

What is the anticipated growth for hospitals as an end-use segment in the Neurovascular Devices Market?

The hospitals segment is anticipated to grow from 2.09 USD Billion in 2024 to 4.0 USD Billion by 2035. Read More

How does the growth of the Neurovascular Devices Market compare across different end-use segments?

The growth across end-use segments indicates that hospitals, specialty clinics, and ambulatory surgical centers are all expected to see substantial increases, with hospitals leading the way. Read More

Neurovascular Devices Market

Q: What are the main segments of the Neurovascular Devices Market?

The main segments of the Neurovascular Devices Market include Interventional Neurology Devices, Neurovascular Stents, Embolic Agents, Catheters, and Flow Diverters. Read More

ID: MRFR/MED/4096-CR

173 Pages

Vikita Thakur

Last Updated: June 05, 2026

Neurovascular Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Interventional Neurology Devices, Neurovascular Stents, Embolic Agents, Catheters, Flow Diverters), By Applications (Aneurysm Treatment, Arteriovenous Malformation Treatment, Intracranial Atherosclerotic Disease, Ischemic Stroke, Hemorrhagic Stroke), By End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Mechanical Thrombectomy Guideline Expansion | |
  2. 3.1.2 Reimbursement Broadening Across Key Markets | |
  3. 3.1.3 Robotic Navigation and AI-Guided Catheter Systems | |
  4. 3.1.4 Aging Population and Rising Global Stroke Incidence | |
  5. 3.1.5 Flow-Diverter and Next-Gen Coiling Innovation | |
  6. 3.1.6 Ambulatory Surgical Center Procedure Migration |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Capital Cost of Robotic and Imaging Platforms | |
  2. 3.2.2 Stringent EU MDR Re-Certification Timelines | |
  3. 3.2.3 Shortage of Trained Neuro-Interventionalists | |
  4. 3.2.4 Product Recall and Safety-Signal Risk | |
  5. 3.2.5 Reimbursement Lag in Emerging Economies |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 AI-Powered Stroke Triage and Decision-Support Software | |
  2. 3.3.2 Ambulatory Surgical Center Expansion for Elective Procedures | |
  3. 3.3.3 Emerging-Market Infrastructure Investment | |
  4. 3.3.4 Data Monetization Through Procedural Analytics Platforms | |
  5. 3.3.5 Next-Generation Flow Diverters and Biodegradable Stents |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Neurovascular Devices Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product | |
  1. 5.1.1 Aneurysm Coiling & Embolization Devices | |
  2. 5.1.2 Cerebral Balloon Angioplasty & Stenting Systems | |
  3. 5.1.3 Neurothrombectomy Devices | |
  4. 5.1.4 Other Products |
2. 5.2 By Target Disease | |
  1. 5.2.1 Ischemic Stroke | |
  2. 5.2.2 Cerebral Aneurysm | |
  3. 5.2.3 Other Target Diseases |
3. 5.3 By End User | |
  1. 5.3.1 Hospitals | |
  2. 5.3.2 Ambulatory Surgical Centers | |
  3. 5.3.3 Other End Users
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Medtronic plc | |
  2. 7.3.2 Stryker Corporation | |
  3. 7.3.3 Penumbra Inc. | |
  4. 7.3.4 MicroVention (Terumo) | |
  5. 7.3.5 Johnson & Johnson (Cerenovus) | |
  6. 7.3.6 Balt Group | |
  7. 7.3.7 Phenox GmbH | |
  8. 7.3.8 MicroPort Scientific | |
  9. 7.3.9 Acandis GmbH | |
  10. 7.3.10 Wallaby Medical
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Integrated Procedural Guidance |
2. 8.2 Robotic-Assisted Remote Intervention |
3. 8.3 Value-Based Reimbursement and Outcome Bundling |
4. 8.4 Sustainability and Supply-Chain Resilience
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Neurovascular Devices Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Neurovascular Devices Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Neurovascular Devices Market — Driver Impact Analysis |
TABLE 4 Global Neurovascular Devices Market — Restraint Impact Analysis |
TABLE 5 Global Neurovascular Devices Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 6 Global Neurovascular Devices Market Size, by Target Disease, 2021–2035 (USD Billion) |
TABLE 7 Global Neurovascular Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 8 Global Neurovascular Devices Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 9 North America Neurovascular Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Europe Neurovascular Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Asia-Pacific Neurovascular Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 South America Neurovascular Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 Middle East & Africa Neurovascular Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Competitive Benchmarking Matrix — Global Neurovascular Devices Market, 2025 |
TABLE 15 Company Profiles — Key Players, Global Neurovascular Devices Market |
TABLE 16 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 17 Report Scope & Methodology Summary |
TABLE 18 Detailed Sources and Citations |
TABLE 19 North America Neurovascular Devices Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 20 North America Neurovascular Devices Market Size, by Target Disease, 2021–2035 (USD Billion) |
TABLE 21 North America Neurovascular Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 22 Europe Neurovascular Devices Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 23 Europe Neurovascular Devices Market Size, by Target Disease, 2021–2035 (USD Billion) |
TABLE 24 Europe Neurovascular Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 25 Asia-Pacific Neurovascular Devices Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 26 Asia-Pacific Neurovascular Devices Market Size, by Target Disease, 2021–2035 (USD Billion) |
TABLE 27 Asia-Pacific Neurovascular Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 28 South America Neurovascular Devices Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 29 South America Neurovascular Devices Market Size, by Target Disease, 2021–2035 (USD Billion) |
TABLE 30 South America Neurovascular Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 31 Middle East & Africa Neurovascular Devices Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 32 Middle East & Africa Neurovascular Devices Market Size, by Target Disease, 2021–2035 (USD Billion) |
TABLE 33 Middle East & Africa Neurovascular Devices Market Size, by End User, 2021–2035 (USD Billion)
13 LIST OF FIGURES |
FIGURE 1 Neurovascular Devices Market Dynamics — Drivers, Restraints, and Opportunities |
FIGURE 2 Industry Value Chain Analysis — Neurovascular Devices Market |
FIGURE 3 Porter's Five Forces Analysis — Neurovascular Devices Market |
FIGURE 4 Global Neurovascular Devices Market Size Trend & Forecast (USD Billion), 2021–2035 |
FIGURE 5 Neurovascular Devices Market Share, by Product (%), 2025 |
FIGURE 6 Neurovascular Devices Market Share, by Target Disease (%), 2025 |
FIGURE 7 Neurovascular Devices Market Share, by End User (%), 2025 |
FIGURE 8 Neurovascular Devices Market Share, by Region (%), 2025 |
FIGURE 9 North America Neurovascular Devices Market Size Trend (USD Billion), 2021–2035 |
FIGURE 10 Europe Neurovascular Devices Market Size Trend (USD Billion), 2021–2035 |
FIGURE 11 Asia-Pacific Neurovascular Devices Market Size Trend (USD Billion), 2021–2035 |
FIGURE 12 South America Neurovascular Devices Market Size Trend (USD Billion), 2021–2035 |
FIGURE 13 Middle East & Africa Neurovascular Devices Market Size Trend (USD Billion), 2021–2035 |
FIGURE 14 Competitive Landscape — Market Share Analysis, 2025 |
FIGURE 15 Competitive Benchmarking Radar Chart — Top 10 Players

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment (2025)	Fastest Growing Segment (2026–2035)
By Product	Aneurysm Coiling & Embolization Devices; Cerebral Balloon Angioplasty & Stenting Systems; Neurothrombectomy Devices; Other Products	Aneurysm Coiling & Embolization Devices	Neurothrombectomy Devices
By Target Disease	Ischemic Stroke; Cerebral Aneurysm; Other Target Diseases	Ischemic Stroke	Cerebral Aneurysm
By End User	Hospitals; Ambulatory Surgical Centers; Other End Users	Hospitals	Ambulatory Surgical Centers
By Geography	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Product

Sub-Segment	Key Trend
Aneurysm Coiling & Embolization Devices	Shift toward softer-fill detachable coils with 360-degree deployment visibility for complex wide-necked aneurysms
Cerebral Balloon Angioplasty & Stenting Systems	Growing use of symptomatic intracranial atherosclerotic stenosis following SAMMPRIS follow-up data re-evaluation
Neurothrombectomy Devices	Large-bore aspiration catheters and stent retrievers competing for first-line acute ischemic stroke treatment
Other Products	Diagnostic micro-catheters and vascular access sheaths supporting upstream procedural workflows

The product landscape is defined by a clear split between the established dominance of aneurysm coiling and embolization devices and the rapid clinical momentum behind neurothrombectomy platforms. Device innovation centers on improving first-pass effect rates and reducing procedural complexity to enable broader adoption in non-academic hospital settings.

By Target Disease

Sub-Segment	Key Trend
Ischemic Stroke	An extended thrombectomy window (up to 24 hours) dramatically expands the eligible patient populations
Cerebral Aneurysm	Population-screening programs and incidental detection are driving elective flow-diverter and coiling demand
Other Target Diseases	Arteriovenous malformation embolization and dural fistula treatment are gaining dedicated device attention

Ischemic stroke commands the largest disease-segment share, reflecting both epidemiological scale and the strength of guideline-backed intervention protocols. Cerebral aneurysm interventions are accelerating as screening programs in high-prevalence populations surface treatable cases earlier in the clinical pathway.

By End User

Sub-Segment	Key Trend
Hospitals	Tertiary comprehensive stroke centers remain the primary procedural setting, supported by advanced imaging and ICU infrastructure
Ambulatory Surgical Centers	Payer approvals for outpatient elective neurovascular procedures are opening a new high-growth channel
Other End Users	Research institutions and military medical facilities contribute to a niche demand for specialized platforms

Hospital dominance reflects the inherent complexity and acuity of neurovascular interventions. The ambulatory surgical center channel is the principal growth story, as reimbursement approvals and safety data for elective procedures accumulate, shifting lower-acuity case volumes toward cost-efficient outpatient settings.

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”